Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Assessing the value of autologous and allogeneic cells for regenerative medicine.

Mason C, Dunnill P.

Regen Med. 2009 Nov;4(6):835-53. doi: 10.2217/rme.09.64. Review.

PMID:
19903003
2.

Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors.

Mason C, Dunnill P.

Regen Med. 2009 Mar;4(2):153-7. doi: 10.2217/17460751.4.2.153. Review. No abstract available.

PMID:
19317634
3.

The need for a regen industry voice.

Mason C, Dunnill P.

Regen Med. 2008 Sep;3(5):621-31. doi: 10.2217/17460751.3.5.621. No abstract available.

4.

The crucial linkage required between regenerative medicine bioprocessors and clinicians.

Mason C, Dunnill P.

Regen Med. 2008 Jul;3(4):435-42. doi: 10.2217/17460751.3.4.435. Review. No abstract available.

5.

The strong financial case for regenerative medicine and the regen industry.

Mason C, Dunnill P.

Regen Med. 2008 May;3(3):351-63. doi: 10.2217/17460751.3.3.351.

6.

Micro biochemical engineering to accelerate the design of industrial-scale downstream processes for biopharmaceutical proteins.

Titchener-Hooker NJ, Dunnill P, Hoare M.

Biotechnol Bioeng. 2008 Jun 15;100(3):473-87. doi: 10.1002/bit.21788.

PMID:
18438873
7.

A brief definition of regenerative medicine.

Mason C, Dunnill P.

Regen Med. 2008 Jan;3(1):1-5. No abstract available.

8.

Lessons for the nascent regenerative medicine industry from the biotech sector.

Mason C, Dunnill P.

Regen Med. 2007 Sep;2(5):753-6. No abstract available.

9.

Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries.

Fedson DS, Dunnill P.

J Public Health Policy. 2007;28(3):322-40.

PMID:
17717543
10.

New approaches to confronting an imminent influenza pandemic.

Fedson DS, Dunnill P.

Perm J. 2007 Summer;11(3):63-9.

PMID:
21461116
Free PMC Article
11.

Translational regenerative medicine research: essential to discovery and outcome.

Mason C, Dunnill P.

Regen Med. 2007 May;2(3):227-9. No abstract available.

12.

Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads.

Markusen JF, Mason C, Hull DA, Town MA, Tabor AB, Clements M, Boshoff CH, Dunnill P.

Tissue Eng. 2006 Apr;12(4):821-30.

PMID:
16674295
13.

A DNA flu vaccine in practice.

Dunnill P.

Nat Biotechnol. 2006 Feb;24(2):139. No abstract available.

PMID:
16465150
14.

Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

Hoare M, Levy MS, Bracewell DG, Doig SD, Kong S, Titchener-Hooker N, Ward JM, Dunnill P.

Biotechnol Prog. 2005 Nov-Dec;21(6):1577-92. Review.

PMID:
16321039
15.

Doppler optical coherence tomography for measuring flow in engineered tissue.

Mason C, Markusen JF, Town MA, Dunnill P, Wang RK.

Biosens Bioelectron. 2004 Oct 15;20(3):414-23. Review.

PMID:
15494219
16.

The potential of optical coherence tomography in the engineering of living tissue.

Mason C, Markusen JF, Town MA, Dunnill P, Wang RK.

Phys Med Biol. 2004 Apr 7;49(7):1097-115. Review.

PMID:
15128192
17.

Engineering and cell attachment properties of human fibronectin-fibrinogen scaffolds for use in tissue engineered blood vessels.

Harding SI, Afoke A, Brown RA, MacLeod A, Shamlou PA, Dunnill P.

Bioprocess Biosyst Eng. 2002 Apr;25(1):53-9. Epub 2002 Mar 20.

PMID:
14505020
18.

Separation characteristics of liquid nematode cultures and the design of recovery operations.

Young JM, Dunnill P, Pearce JD.

Biotechnol Prog. 2002 Jan-Feb;18(1):29-35.

PMID:
11822896
19.

A comparison of the process issues in expressing the same recombinant enzyme periplasmically in Escherichia coli and extracellularly in Streptomyces lividans.

Pierce JJ, Robinson SC, Ward JM, Keshavarz-Moore E, Dunnill P.

J Biotechnol. 2002 Jan 18;92(3):205-15.

PMID:
11689245
20.

Prediction of the pilot-scale recovery of a recombinant yeast enzyme using integrated models.

Varga EG, Titchener-Hooker NJ, Dunnill P.

Biotechnol Bioeng. 2001 Jul 20;74(2):96-107.

PMID:
11369998
21.

Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering.

Underwood S, Afoke A, Brown RA, MacLeod AJ, Shamlou PA, Dunnill P.

Biotechnol Bioeng. 2001 May 20;73(4):295-305.

PMID:
11283912
22.

Purification of essentially RNA free plasmid DNA using a modified Escherichia coli host strain expressing ribonuclease A.

Cooke GD, Cranenburgh RM, Hanak JA, Dunnill P, Thatcher DR, Ward JM.

J Biotechnol. 2001 Feb 23;85(3):297-304.

PMID:
11173096
23.

Metabolic modeling as a tool for evaluating polyhydroxyalkanoate copolymer production in plants.

Daae EB, Dunnill P, Mitsky TA, Padgette SR, Taylor NB, Valentin HE, Gruys KJ.

Metab Eng. 1999 Jul;1(3):243-54.

PMID:
10937939
24.

Biochemical engineering approaches to the challenges of producing pure plasmid DNA.

Levy MS, O'Kennedy RD, Ayazi-Shamlou P, Dunnill P.

Trends Biotechnol. 2000 Jul;18(7):296-305. Review.

PMID:
10856925
26.

Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical-grade plasmid DNA processing.

Levy MS, Collins IJ, Tsai JT, Shamlou PA, Ward JM, Dunnill P.

J Biotechnol. 2000 Jan 21;76(2-3):197-205.

PMID:
10656334
27.
28.

Rational engineering of the TOL meta-cleavage pathway

Sheridan R, Jackson GA, LR, Ward J, Dunnill P.

Biotechnol Bioeng. 1998 Apr 5;58(2-3):240-9.

PMID:
10191395
29.

Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release.

Ciccolini LA, Shamlou PA, Titchener-Hooker NJ, Ward JM, Dunnill P.

Biotechnol Bioeng. 1998 Dec 20;60(6):768-70.

PMID:
10099486
30.

UCL biochemical engineering.

Shamlou PA, Dunnill P, Hoare M, Ison AP, Keshavarz-Moore E, Lye GJ, Titchener-Hooker NJ, Turner MK, Woodley JM, Buckland BC.

Biotechnol Bioeng. 1998 Dec 5;60(5):527-33. No abstract available.

PMID:
10099460
31.

Factors determining more efficient large-scale release of a periplasmic enzyme from E. coli using lysozyme.

Pierce JJ, Turner C, Keshavarz-Moore E, Dunnill P.

J Biotechnol. 1997 Oct 2;58(1):1-11.

PMID:
9335174
32.
33.

Factors affecting the fermentative production of a lysozyme-binding antibody fragment in Escherichia coli.

Harrison JS, Keshavarz-Moore E, Dunnill P, Berry MJ, Fellinger A, Frenken L.

Biotechnol Bioeng. 1997 Mar 20;53(6):611-22.

PMID:
18634062
34.

Polyvinyl alcohol-coated perfluorocarbon supports for metal chelating affinity separation of a monoclonal antibody.

Morgan PE, Thomas OR, Dunnill P, Sheppard AJ, Slater NK.

J Mol Recognit. 1996 Sep-Dec;9(5-6):394-400.

PMID:
9174916
35.

Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein.

Sloane RP, Ward JM, O'Brien SM, Thomas OR, Dunnill P.

J Biotechnol. 1996 Aug 20;49(1-3):231-8.

PMID:
8879173
36.

High speed centrifugal separator for rapid on-line sample clarification in biotechnology.

Richardson P, Molloy J, Ravenhall R, Holwill I, Hoare M, Dunnill P.

J Biotechnol. 1996 Aug 20;49(1-3):111-8.

PMID:
8879167
37.

Production of cadmium sulphide microcrystallites in batch cultivation by Schizosaccharomyces pombe.

Williams P, Keshavarz-Moore E, Dunnill P.

J Biotechnol. 1996 Jul 31;48(3):259-67.

PMID:
8862002
39.

Monitoring recombinant inclusion body recovery in an industrial disc stack centrifuge.

Jin K, Thomas OR, Dunnill P.

Biotechnol Bioeng. 1994 Mar 15;43(6):455-60.

PMID:
18615741
40.

Application of biochemical engineering principles to develop a recovery process for protein inclusion bodies.

Keshavarz-Moore E, Olbrich R, Hoare M, Dunnill P.

Ann N Y Acad Sci. 1991 Dec 27;646:307-14. No abstract available.

PMID:
1809197
41.

A new biochemical engineering approach to the fractional precipitation of proteins.

Richardson P, Hoare M, Dunnill P.

Biotechnol Bioeng. 1990 Aug 5;36(4):354-66.

PMID:
18595089
42.
43.

Correlation of biocatalytic activity in an organic-aqueous two-liquid phase system with solvent concentration in the cell membrane.

Osborne SJ, Leaver J, Turner MK, Dunnill P.

Enzyme Microb Technol. 1990 Apr;12(4):281-91.

PMID:
1366443
44.

Biochemical engineering challenges of purifying useful proteins.

Hoare M, Dunnill P.

Philos Trans R Soc Lond B Biol Sci. 1989 Aug 31;324(1224):497-507. Review.

PMID:
2573087
45.
46.

Protein precipitate recovery using microporous membranes.

Bentham AC, Ireton MJ, Hoare M, Dunnill P.

Biotechnol Bioeng. 1988 Jun 5;31(9):984-94.

PMID:
18584706
47.
48.

The kinetics of protein precipitation by different reagents.

Chan MY, Hoare M, Dunnill P.

Biotechnol Bioeng. 1986 Mar;28(3):387-93.

PMID:
18555340
49.

Membrane separation of protein precipitates: unstirred batch studies.

Devereux N, Hoare M, Dunnill P.

Biotechnol Bioeng. 1986 Jan;28(1):88-96.

PMID:
18553845

Supplemental Content

Loading ...
Support Center